Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
LONDON - Aurrigo International plc (AIM:AURR), a provider of transport technology solutions, announced on Friday that shareholders approved all resolutions at its General Meeting held earlier in the day.
The company reported that the five resolutions, including authorizations for directors to allot securities and disapply pre-emption rights in connection with a subscription, placing and retail offer, received overwhelming support with nearly 100% approval rates.
Following the approval, Aurrigo expects 19,868,162 new ordinary shares to be admitted to AIM on September 22, 2025. This will increase the company’s total issued ordinary share capital to 89,370,833 shares.
The company noted that a concert party consisting of David Keene, Graham Keene, and Samuel Munslow will hold approximately 27.97% of the voting rights following the admission of the new shares. David and Graham Keene each hold 12,500,000 shares, representing 13.99% of the enlarged share capital.
According to the announcement, no members of the concert party are subscribing to new ordinary shares as part of the placing or retail offer.
The information was disclosed in a press release statement following the company’s General Meeting held on September 19, 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.